Alzheimer's keeps frustrating big pharma
A string of serious setbacks for possible treatments may be eroding researchers' -- and investors' -- confidence.
When some of the world's leading researchers on Alzheimer's meet in Boston in July to discuss therapies and treatments for the so-far incurable neurological disease, will they have any breakthroughs to mention?
Chances are, probably not. Years of research and tests by the pharmaceutical industry, which looks to benefit from patents for an effective Alzheimer's treatment, have so far yielded little to no positive results. And that's leading to questions about whether big pharma might still consider Alzheimer's research cost-effective.
According to the Alzheimer's Association's 2013 Facts and Figures report, one out of every three seniors in the U.S. dies with Alzheimer's or some other form of dementia. The disease, which affects tens of millions of Americans, is also the sixth-leading cause of death in the U.S. So far, it's the only cause of death that science has been unable to prevent, cure or at least show progress in slowing.
Along with the emotional toll on Alzheimer's patients and their families is an enormous financial cost. The number of people with the disease is expected to triple in the next several decades, with estimates that overall costs for Alzheimer's treatment and care could reach $1 trillion annually by 2050.
In 2012, more than 150 companies, including some pharmaceutical giants, were working on Alzheimer's drugs -- hoping to cash in on what the Genetic Engineering & Biotechnology News website estimates is an $8 billion global market for a successful Alzheimer's treatment. But some highly anticipated drugs have since fizzled out in the testing stage.
In January of last year, Medivation (MDVN) announced that its Dimebon drug, backed by Pfizer (PFE), didn't produce any significant results for Alzheimer's patients, leaving Pfizer with about $725 million in lost investment.
And just this week, Baxter International (BAX) reported the blood product it thought might help slow mental decline and preserve physical function in patients with mild to moderate Alzheimer's failed to show the hoped-for results.
All these setbacks, according to The Independent, are affecting the confidence of neuroscience researchers and causing pharmaceutical companies to reconsider their efforts to add Alzheimer's treatments to the medical pipeline.
"My sense is not that companies want to move away (from Alzheimer's research) but that their shareholders are getting restive," Eric Karran, the director of research at Alzheimer's Research UK, told the newspaper in September. "That's capitalism. There is nothing we can do about that. But there is a huge public need."
I'm not a scientist or a Doctor but........... My theory is if you cure diabetes and other metabolic disorders, The occurrence of dementia and Alzheimer's will fall in proportion.
Diet and exercise!!!!!!!!!!!!!!!!!
My feeling is that this has been with us forever, we just live much longer today; Look at timelines over the last 4-5 Generations..
Now that they have stuck fancier names on the disease, it has became a disease....imo.
In the past we were senile, crackers, goofy,forgetful or just plain crazy; When losing our faculties.
Nature's way of letting us slip back to infancy and dying without knowing it's coming..The Secret.
I also believe, that there are external causes, such as diet, chemicals in foods and waters, along with pollution; The air we breath in larger Metro areas, that may be a catalyst for the earlier onsets..
And the lack of interest and mobility that effects many seniors...But not all of us give up easily.
There may be and are genetic connections, that seem to be apparent; ??
Does it skip a generation or is it a constant? My sisters and I hope so, because we think about it most days...And I don't want to burden my wife with it, nor my children..
We have seen some families that are inflicted more then others, and it begs the questions.
I think pre-med treatment is much more effective then after the fact..?
We also believe in constantly excercising the brain with activity, is the best way to slow the process along with a balanced diet and other physical activities or excercise...
Some of the other suggestions here(within comments) may help..Don't know for sure..?
Such things as TV, Radio, Music, Reading, Computers, Puzzles, Games and outside activities do help? Once you stop it seems to get worst.
Afterall it is a problem in the Brain...Not your legs,arms and fingers, like Arthiritis.
After losing our Mom over 16 years ago, we have learned much and have witnessed the on-going degeneration of many others...Until their deaths.
So if your Mom is still alive, give her a kiss for me; Wish her Happy Mother's Day and be very glad that she is still around; And she knows who you are?, one of her Children.
Happy Mother's Day to all Moms.
Alzheimer, what a great way to die. With Alzheimer you have no idea where your are or how to care for yourself any longer. If you had Alzheimer's just 50 years ago you would have died much sooner with out putting a major financial burden on the immediate family or society as a whole.
Just think with Alzheimer's .....you don't even know your dyeing. You just sort of drift off into "lolla land" and never come back....and if you would have taken that walk into the woods you would have died a natural death. But today, society will not let that happen. Their is just to much money to be made in health care to ever let that happen .....and......money today rules the force of nature.
Copyright © 2014 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
[BRIEFING.COM] The stock market finished an upbeat week on a mixed note. The S&P 500 added just over a point, holding its weekly gain at 1.0% while the Nasdaq lost 0.4%.
The major averages began the day on an upbeat note, but relinquished their opening gains during the first 90 minutes of action. The early sentiment was boosted by a better-than-expected nonfarm payrolls report for February (175K versus Briefing.com consensus 163K), but a closer look into the report suggested that ... More
More Market News
The solid report comes a month after the retailer closed all of its Canadian operations.
MUST-SEE ON MSN
- Video: Easy DIY smoked meats at home
A charcuterie master shares his process for cold-smoking meat at home.
- Jetpacks about to go mainstream
- Weird things covered by home insurance
- Bing: 70 percent of adults report 'digital eye strain'